BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37132738)

  • 21. Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
    Mu W; Cordner ZA; Yuqi Wang K; Reed K; Robinson G; Mitchell S; Lin D
    Genet Med; 2018 Jun; 20(6):639-644. PubMed ID: 29048420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
    Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
    Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case report of hereditary hemorrhagic telangiectasia in children and literature review].
    Liu JR; Liu H; Wang B; Zhang YH; Xu H; Tang XL; Li HM; Zhao SY
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):674-678. PubMed ID: 32842389
    [No Abstract]   [Full Text] [Related]  

  • 27. An update on the ophthalmic features in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).
    Abdolrahimzadeh S; Formisano M; Marani C; Rahimi S
    Int Ophthalmol; 2022 Jun; 42(6):1987-1995. PubMed ID: 35034241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis.
    McDonald J; Bayrak-Toydemir P; Pyeritz RE
    Genet Med; 2011 Jul; 13(7):607-16. PubMed ID: 21546842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH.
    Mahmoud M; Borthwick GM; Hislop AA; Arthur HM
    Lab Invest; 2009 Jan; 89(1):15-25. PubMed ID: 19015642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations.
    Adam Z; Brančiková D; Romanová G; Pour L; Krejčí M; König J; Nebeský T; Adamová Z; Štork M; Krejčí M; Ševčíková S; Eid M; Král Z
    Vnitr Lek; 2021; 67(6):339-344. PubMed ID: 35459376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia.
    Anderson E; Sharma L; Alsafi A; Shovlin CL
    Thorax; 2022 Jun; 77(6):628-630. PubMed ID: 35165143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriovenous Malformations in the Setting of Osler-Weber-Rendu: What the Radiologist Needs to Know.
    Lantz KE; Armstrong SQ; Butt F; Wang ML; Hardman R; Czum JM
    Curr Probl Diagn Radiol; 2022; 51(3):375-391. PubMed ID: 33827770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease).
    Sabbà C; Pasculli G; Cirulli A; Gallitelli M; Virgilio G; Resta F; Guastamacchia E; Palasciano G
    Minerva Cardioangiol; 2002 Jun; 50(3):221-38. PubMed ID: 12107402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
    Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
    Stuhrmann M; El-Harith el-HA
    Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.